Randomized clinical trials of patients with acute myocardial infarction-related cardiogenic shock:A systematic review of used cardiogenic shock definitions and outcomes

Autor: Johannes Grand, Christian Hassager, Martin Frydland, Jakob Josiassen, Jacob E. Møller, Anders Perner
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Josiassen, J, Frydland, M, Hassager, C, Møller, J E, Perner, A & Grand, J 2021, ' Randomized clinical trials of patients with acute myocardial infarction-related cardiogenic shock : A systematic review of used cardiogenic shock definitions and outcomes ', Kardiologia Polska, vol. 79, no. 9, pp. 1003-1015 . https://doi.org/10.33963/KP.A2021.0072
DOI: 10.33963/KP.A2021.0072
Popis: Background: Cardiogenic shock (CS) is a critical complication to acute myocardial infarction (AMI), with short-term mortality rates exceeding 40%. However, no international consensus of a CS definition exists. This may compromise interstudy comparability. Aims: The aim of the current study was to review differences and similarities of CS enrolment criteria in AMI-related CS randomized clinical trials (RCT). Methods: From the electronic databases MEDLINE and EMBASE we identified all AMI-related CS trials. Results: A total of 19 trials comprising a total of 2674 unique patients with CS were identified. Seven trials investigated left ventricular assist devices, eight investigated medical treatments, three percutaneous coronary intervention (PCI), and one trial investigated targeted temperature management. The inclusion criteria, baseline hemodynamics, endpoints, and mortality varied markedly between trials. Hypotension was the most frequent overall inclusion criterion (17 [90%] trials), and a systolic blood pressure
Databáze: OpenAIRE